Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.55% |
| 2 | Technology | 20.49% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRRA
1976
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $2.31M | ﹤0.01% |
105,274
-900
| -0.8% | -$18K |
|
1977
iShares S&P 500 Growth ETF
IVW
$77.6B
| $2.31M | ﹤0.01% |
+31,200
| New | +$2.38M |
|
|
RTC
1978
DELISTED
Baijiayun Group
RTC
| $2.3M | ﹤0.01% |
48,491
-3,840
| -7% | -$193K |
|
1979
Ameren
AEE
$30.4B
| $2.3M | ﹤0.01% |
+28,400
| New | +$2.42M |
|
|
MANT
1980
DELISTED
Mantech International Corp
MANT
| $2.3M | ﹤0.01% |
30,300
+7,800
| +35% | +$638K |
|
1981
Turning Point Brands
TPB
$1.75B
| $2.3M | ﹤0.01% |
48,152
-83,145
| -63% | -$3.99M |
|
1982
Monarch Casino & Resort
MCRI
$2.22B
| $2.3M | ﹤0.01% |
+34,300
| New | +$2.22M |
|
|
CASA
1983
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $2.3M | ﹤0.01% |
338,800
-67,100
| -17% | -$495K |
|
|
RBNC
1984
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $2.29M | ﹤0.01% |
72,325
+1,312
| +2% | +$37.4K |
|
1985
Clarus
CLAR
$140M
| $2.28M | ﹤0.01% |
89,127
-132,265
| -60% | -$3.65M |
|
1986
Dyne Therapeutics
DYN
$4.8B
| $2.28M | ﹤0.01% |
+140,500
| New | +$2.49M |
|
1987
Super Micro Computer
SMCI
$25.8B
| $2.27M | ﹤0.01% |
621,400
+498,000
| +404% | +$1.81M |
|
1988
STAG Industrial
STAG
$7.09B
| $2.27M | ﹤0.01% |
+57,800
| New | +$2.36M |
|
1989
Tredegar Corp
TG
$276M
| $2.27M | ﹤0.01% |
186,100
+36,200
| +24% | +$464K |
|
|
IVAC
1990
DELISTED
Intevac Inc
IVAC
| $2.27M | ﹤0.01% |
474,177
-53,292
| -10% | -$292K |
|
|
AMK
1991
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $2.27M | ﹤0.01% |
91,100
+554
| +0.6% | +$14.3K |
|
|
GBL
1992
DELISTED
GAMCO Investors, Inc.
GBL
| $2.27M | ﹤0.01% |
85,900
-300
| -0.3% | -$8.01K |
|
1993
Edgewell Personal Care
EPC
$1.31B
| $2.27M | ﹤0.01% |
+62,400
| New | +$2.56M |
|
|
TECX
1994
Tectonic Therapeutic
TECX
$682M
| $2.26M | ﹤0.01% |
33,758
+26,341
| +355% | +$2.16M |
|
1995
Silgan Holdings
SLGN
$4.49B
| $2.26M | ﹤0.01% |
58,880
+5,100
| +9% | +$208K |
|
1996
Champions Oncology
CSBR
$70.4M
| $2.26M | ﹤0.01% |
221,146
-6,900
| -3% | -$70.2K |
|
1997
First Internet Bancorp
INBK
$254M
| $2.26M | ﹤0.01% |
72,400
-7,700
| -10% | -$233K |
|
|
VWTR
1998
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $2.25M | ﹤0.01% |
197,900
-2,200
| -1% | -$28.8K |
|
1999
Upland Software
UPLD
$15.7M
| $2.24M | ﹤0.01% |
6,712
-4,740
| -41% | -$1.78M |
|
|
CYBR
2000
DELISTED
CyberArk
CYBR
| $2.24M | ﹤0.01% |
14,200
-104,300
| -88% | -$15.9M |
|
Similar funds
Jim Simons's Q3 2021 Portfolio in Review
As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
- Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
- Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Jim Simons opened 663 new positions and closed 653 in Q3 2021.
- Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.